Patents by Inventor Lee Charles Claridge

Lee Charles Claridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of VAP-1 inhibitors for treating fibrotic conditions
    Patent number: 10576148
    Abstract: The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: March 3, 2020
    Assignees: BIOTIE THERAPIES CORP., THE UNIVERSITY OF BIRMINGHAM
    Inventors: Christopher Weston, Lee Charles Claridge, David Adams, David Smith, Nina Westerlund, Marjo Pihlavisto, Thua Österman
  • USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS
    Publication number: 20180071388
    Abstract: The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.
    Type: Application
    Filed: September 21, 2017
    Publication date: March 15, 2018
    Applicants: BIOTIE THERAPIES CORP., THE UNIVERSITY OF BIRMINGHAM
    Inventors: Christopher WESTON, Lee Charles CLARIDGE, David ADAMS, David SMITH, Nina WESTERLUND (DECEASED), Marjo PIHLAVISTO, Thua ÖSTERMAN (DECEASED)
  • Use of VAP-1 inhibitors for treating fibrotic conditions
    Patent number: 9795671
    Abstract: The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.
    Type: Grant
    Filed: September 7, 2010
    Date of Patent: October 24, 2017
    Assignees: BIOTIE THERAPIES CORP., THE UNIVERSITY OF BIRMINGHAM
    Inventors: Christopher Weston, Lee Charles Claridge, David Adams, David Smith, Nina Westerlund, Max Ole Valdemar Westerlund, Marjo Pihlavisto, Thua Österman, Elina Ainomaija Antikainen
  • USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS
    Publication number: 20130195883
    Abstract: The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method.
    Type: Application
    Filed: September 7, 2010
    Publication date: August 1, 2013
    Applicants: THE UNIVERSITY OF BIRMINGHAM, BIOTIE THERAPIES CORP.
    Inventors: Christopher Weston, Lee Charles Claridge, David Adam, David Smith, Nina Westerlund, Marjo Pihlavisto, Thua Österman